首页> 外文学位 >(Ru(II)(hedta))(-) complexes of pyrimidine, pyridazine, and pyrazinium ligands: Studies of eta(2) and fluxional behavior
【24h】

(Ru(II)(hedta))(-) complexes of pyrimidine, pyridazine, and pyrazinium ligands: Studies of eta(2) and fluxional behavior

机译:嘧啶,哒嗪和吡嗪鎓配体的(Ru(II)(hedta))(-)配合物:eta(2)和流动行为的研究

获取原文
获取原文并翻译 | 示例

摘要

The reaction of (Rd$sp{rm II}$(hedta)) $sp{-}$ (hedta$sp{3-}$ = N-hydroxyethylenediaminetriacetate) with various N-heterocycles including pyrimidine, pyrazine and pvridazine have been studied predominantly by $sp1$H/$sp{13}$C NMR and electrochemical methods. It has been shown that pyrimidine and other N-heterocycles first substitute for H$sb2$O forming N-bound complexes. However, migration to other locations which are shown to be novel $etasp2$ attachments to the pyrimidine ring at $etasp2$(1,2), $etasp2$(1,6) and $etasp2$(5,6) locations occur with changes in NMR and electrochemical properties of the ligand at 1:1 stoichiometry. Both the N-1 bound and $etasp2$ species are stereochemically rigid at 298 K. However, when two pyrimidines are coordinated (N-l)by displacement of a cis-carboxylate donor of hedta$sp{3-},$ one pyrimidine is fluxional with linkage 1,3-isomerism and the other pyrimidine remains stereochemically rigid. The process of N-1 to $etasp2$ migration is suppressed as the Ru-N $sigma$ bond is strengthened by donating ligand substituents (CH$sb3$ group) and favored by exo-ring oxo substituents in DNA nucleobases.;Pyrazine as a ligand is observed to bind initially to all three stereochemical isomers of (Ru$sp{rm II}$(hedta)) $sp{-}.$ Two isomers (cis-equatorial and trans-equatorial) are rigid complexes, whereas the cis-polar pyrazine complexes is fluxional. An equilibrium shift proceeds in ca. 2h to completion in an entropy driven manner to produce only N-bound cis-polar isomer which has the coordinated ligand undergoing 1,4-metallotropic shifts. Migration to $etasp2$-binding sites is initiated by protonation of the terminal N-4 nitrogen. The process weakens Ru-N $sigma$ bonding to the pyrazine which allows a shift to more favorable $etasp2$ locations on coordinated pyrazinium ion. The shift is again retarded by electron releasing CH$sb3$ groups.;Pyridazine as a ligand follows patterns similar to the N-bonded pyrimidines. However, the stronger $sigma$ donation of pyridazine prevents fluxional behavior or $etasp2$ migration for either mono or bis complexes. A bidentate mono complex with weakened coordination is implied by kinetic effects.;Since the $sp{13}$C NMR shifts and some $sp1$H NMR shifts which are observed for the $etasp2$(C=N) pyrimidine complexes are unusual in comparison with known $etasp2$(C=C) olefinic complexes of Ru$sp{rm II}$ and Os$sp{rm III}$ complexes in the literature, a model complex possessive of a single $etasp2$(C=N) binding site was prepared using 6-azauridine as a ligand for (Ru$sp{rm II}$(hedta)) $sp{-}$. It has been shown that the Ru(II) complexes which is produced initially with 6-azauridine forms by substitution at N-6. This N-bound isomer (complex (1)) undergoes sequential migration to the adjacent $etasp2$(5,6) position with 100% conversion (complex (2)) when the pH $le$ 2. However, above pH $approx$ 4, a second migration occurs to the deprotonated N-1 position of 6-azauridine, followed by N-1, O-4 chelation (complex (3)). By means of pH control, it was shown that the $etasp2$-bound complex (2) has $sp{13}$C and $sp1$H NMR parameters similar to the pyrimidine $etasp2$ complexes, e.g. that $sp{13}$C chemical shifts of $etasp2$ (C=N) chromophores exhibit small downfield shifts, not large (ca. 80 ppm) upfield shifts as for $etasp2$ (C=C) species.;Lastly it is shown that 2,3-dimethylpyrazine forms (Ru$sp{rm II}$(hedta)(2,3-Me$sb2$Pz)) $sp{-}$ and bridged-binuclear complex ${$(Ru$sp{rm II}$(hedta)) $sb2$(2,3-Me2Pz)) $}sp{2-}.$ In the bridged complex, $sp1$H NMR data shows that coordination the two Ru$sp{rm II}$ is asymmetric. This is attributed to steric factors and electronic factors promoting better donation to one Ru(II) center at the expense of the second Ru(II) site.
机译:研究了(Rd $ sp {rm II} $(hedta))$ sp {-} $(hedta $ sp {3-} $ = N-羟基乙二胺三乙酸酯)与各种N杂环的反应,包括嘧啶,吡嗪和对rid哒嗪主要通过$ sp1 $ H / $ sp {13} $ C NMR和电化学方法进行。已经显示嘧啶和其他N-杂环首先替代形成H-sb2 $ O的N-结合复合物。但是,迁移到显示为$ etasp2 $(1,2),$ etasp2 $(1,6)和$ etasp2 $(5,6)位置的嘧啶环上有新颖的$ etasp2 $嘧啶环的其他位置时,会发生以下情况:以1:1的化学计量比改变NMR和配体的电化学性质。 N-1结合的物种和$ etasp2 $物种在298 K时都具有立体化学刚性。但是,当两个嘧啶嘧啶通过取代hedta $ sp {3-}的顺式羧酸酯供体而配位(Nl)时,一个嘧啶是可熔的具有1,3-异构体的键合,另一个嘧啶在立体化学上仍然是刚性的。 N-1到$ etasp2 $的迁移过程受到抑制,因为通过捐赠配体取代基(CH $ sb3 $基团)增强了Ru-N $ sigma $键,并通过脱除DNA核碱基中的氧代环取代基来促进。观察到一个配体最初与(Ru $ sp {rm II} $(hedta))$ sp {-}的所有三个立体化学异构体结合。$两个异构体(顺-赤道和反赤道)是刚性复合物,而顺式吡嗪复合物是流动性的。大约在大约30分钟内进行平衡移动。 2h以熵驱动的方式完成,以仅产生具有经配位的配体经历1,4-金属向位移的N-结合的顺式-极性异构体。通过末端N-4氮的质子化作用,开始迁移至$ etasp2 $-结合位点。此过程减弱了Ru-Nσ与吡嗪的键合,从而使向配位吡嗪鎓离子上的etasp2 $位置更有利。电子释放的CH $ sb3 $基团再次阻止了这种转变。哒嗪作为配体遵循与N键合的嘧啶类似的模式。但是,对哒嗪的$ sigma $较强的捐赠阻止了单或双配合物的通量行为或etasp2 $迁移。动力学效应暗示了双齿单价配合物的配位作用减弱。;由于观察到$ etasp2 $(C = N)嘧啶配合物的$ sp {13} $ C NMR位移和一些$ sp1 $ H NMR位移是不寻常的与文献中Ru $ sp {rm II} $和Os $ sp {rm III} $配合物的已知$ etasp2 $(C = C)烯烃配合物相比,模型配合物拥有单个$ etasp2 $(C = N)结合位点是使用6-氮杂尿苷作为(Ru $ sp {rm II} $(hedta))$ sp {-} $的配体制备的。已经表明,最初通过6-氮杂鸟苷形式通过在N-6处取代而生成的Ru(II)络合物。当pH值$ 2时,此N结合异构体(复合物(1))经历顺序迁移至相邻的$ etasp2 $(5,6)位置,且转化率为100%(复合物(2))。 $ 4,第二迁移发生在6-氮杂尿嘧啶的去质子化的N-1位置,随后是N-1,O-4螯合(复合物(3))。通过pH控制显示,结合$ etasp2 $的配合物(2)具有类似于嘧啶$ etasp2 $配合物的$ sp {13} $ C和$ sp1 $ H NMR参数。 $ etasp2 $(C = N)发色团的$ sp {13} $ C化学位移表现出小的下场漂移,而不是$ etasp2 $(C = C)物种的大场漂移(约80 ppm)。显示了2,3-二甲基吡嗪形式(Ru $ sp {rm II} $(hedta)(2,3-Me $ sb2 $ Pz))$ sp {-} $和桥联双核复合物$ {$(Ru $ sp {rm II} $(hedta))$ sb2 $(2,3-Me2Pz))$} sp {2-}。$在桥接复合物中,$ sp1 $ H NMR数据表明两个Ru $ sp { rm II} $是不对称的。这归因于空间因素和电子因素,它们促进了向一个Ru(II)中心的更好捐赠,但又牺牲了第二个Ru(II)场所。

著录项

  • 作者

    Chen, Ya.;

  • 作者单位

    University of Pittsburgh.;

  • 授予单位 University of Pittsburgh.;
  • 学科 Biochemistry.;Organic chemistry.
  • 学位 Ph.D.
  • 年度 1997
  • 页码 234 p.
  • 总页数 234
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号